GlassScriptPhysician profile
Marquee G Ricks
NPI 1902429392
$2,042.73
in general payments reported to CMS, 2019-2025
18 companies · $278 in 2025
The $278 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $130 · 2022: $633 · 2023: $417 · 2024: $584 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,279.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,302.64 | 2021-2025 | |
| Amgen INC. | $197.25 | 2022-2024 | Otezla |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $88.64 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $77.36 | 2022 | |
| Lilly USA, LLC | $50.31 | 2023-2025 | Mounjaro, Zepbound |
| Mayne Pharma Commercial LLC | $34.04 | 2023-2025 | |
| Dexcom, INC. | $33.08 | 2024 | Dexcom G6 Transmitter |
| Celgene Corporation | $32.69 | 2024 | Zeposia |
| Pfizer INC. | $31.83 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.63 | 2021-2025 | Xifaxan |
| Exact Sciences Corporation | $29.12 | 2024 | Cologuard Collection Kit |
| Astellas Pharma US INC | $26.61 | 2023 | Veozah |
| Axsome Therapeutics, INC. | $26.06 | 2024 | Auvelity |
| Exeltis, USA INC. | $22.84 | 2023 | Slynd |
| Xeris Pharmaceuticals, INC. | $21.58 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $15.38 | 2024 | Ajovy |
| Biohaven Pharmaceuticals, INC. | $12.55 | 2021 | |
| Boston Scientific Corporation | $11.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marquee Ricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.